Article

(2023) Anti HER-2 aptamer functionalized gold nanoparticles of dasatinib for targeted chemo-radiotherapy in breast cancer cells. Biomaterials Advances.

(2020) Development of a novel liposomal nanoparticle formulation of cisplatin to breast cancer therapy. Journal of cellular biochemistry. ISSN 1097-4644

(2018) Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy. Artificial cells, nanomedicine, and biotechnology. pp. 1-17. ISSN 2169-141X

(2018) A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery. Artificial cells, nanomedicine, and biotechnology. pp. 169-177. ISSN 2169-141X

(2017) New liposomal doxorubicin nanoformulation for osteosarcoma: Drug release kinetic study based on thermo and pH sensitivity. Chemical biology & drug design. ISSN 1747-0285

(2017) A Novel Approach on Drug Delivery: Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines. Cell journal. pp. 55-65. ISSN 2228-5806